About

John P. Smith, DO, completed his undergraduate work at Utah Valley University, majoring in basic sciences. He then attended Medical School at the Texas College of Osteopathic Medicine in Fort Worth, Texas. He graduated from Family Practice Residency at Long Island Community Medical Center in Patchogue, New York, and completed a Genitourinary Medicine Fellowship at the Smith Institute for Urology in Lake Success, New York. Dr. Smith is board-certified in Family Medicine and has completed a Fellowship in Genitourinary Medicine. His clinical expertise includes men's health, urology, cystoscopy, and vasectomy. Dr. Smith brings a unique perspective to the Division of Urology with a goal to provide high-quality, evidence-based urologic care in a comfortable and compassionate environment.

Research topics

• Medicine
• Political Science
• Nursing
• Psychiatry
• Computer Science
• Psychology
• Sociology
• Business
• Family medicine
• Internal medicine
• Knowledge management
• Computer Security
• Surgery
• Medical education
• Process management
• Engineering
• Public relations
• Data science
• Anesthesia
• Bioinformatics
• Gerontology
• Management science
• Pathology
• Environmental health

Selected publications

• Validation of the Observational Assessment Tool for Tailoring (OATT)

  Prevention Science · 2026-01-30

  articleOpen accessSenior author

  Individually tailored interventions can address the myriad multi-level determinants of chronic health conditions. Limited measurement modalities to quantify tailoring disallow examining "active ingredient" effects on outcomes and implementation fidelity. The objective of this study is to develop and validate the Observational Assessment Tool for Tailoring (OATT) for behavioral prevention interventions. We developed the OATT and coded n = 172 videorecorded sessions from two trials of the Family Check-Up® 4 Health (FCU4Health), an individually tailored prevention and management program for behavioral health and obesogenic behaviors with English and Spanish-speaking participants. The sample was culturally diverse (> 65% Hispanic/Latino). Confirmatory factor analysis (CFA) tested the two-factor model. McDonald's Omega estimated internal consistency. Discriminant and predictive validity tests were conducted with FCU4Health fidelity, engagement, and health behavior outcomes, informed by the Implementation Cascade Model. CFA confirmed a two-factor structure for both trials (i.e., RMSEA ≤ 0.06, CFI and TLI of ≥ 0.95, SRMR < 0.08 chi-square p ≥ 0.05). Reliability and inter-rater reliability were good (ICC > 0.77) for both trials and English and Spanish videos. The OATT was not correlated (p > 0.05) with discriminant validity variables. Path analysis for predictive validity indicated that fidelity to the Individualized Treatment Planning factor directly predicts improvements in participant engagement (B = 0.16, p = 0.01, 95% CI [0.03-0.29]), which directly predicts improvements in parent health behaviors 12 months post-baseline (B = 0.18, p = 0.01, 95% CI [0.02-0.34]). The development of the OATT is a critical step to measure and guide tailored intervention development, implementation, and evaluation. Future studies are needed to replicate predictive validity findings and test the OATT factor structure with larger samples and different prevention initiatives.

  PublisherOA PDFDOI

• Psychometric properties of the Clinical Sustainability Assessment Tool (CSAT) short form across three research centers evaluating effectiveness and implementation of a cancer symptom surveillance and management intervention

  Implementation Science Communications · 2026-01-29 · 1 citations

  articleOpen access

  Abstract Objective The Clinical Sustainability Assessment Tool (CSAT) is designed to capture determinants of sustainable clinical practices over time. Although the full 49-item CSAT instrument has demonstrated strong psychometric properties, the 21-item short form has had limited evaluation. This study aimed to assess the CSAT short form (CSAT Short) across different respondent characteristics and care delivery settings. Methods We evaluated the CSAT Short in a sample of healthcare personnel ( N = 256 respondents) drawn from across three hybrid effectiveness-implementation studies in a research consortium, all of which tested routine symptom surveillance and integration of symptom management interventions in ambulatory oncology care settings in the US. Confirmatory factor analyses (CFA) and mIRT were conducted to assess the CSAT Short's fit to the hypothesized factor structure. Multiple-group CFA was used to test for measurement invariance across groups of respondents with different professional roles, years in current role, and different work settings. Results The hypothesized seven factor structure of the CSAT Short exhibited good fit to the data and strong internal consistency in our sample of healthcare personnel drawn from across three large pragmatic trials (CFI = .99,TLI = .98, X 2 (182) = 658.99, p &lt; .001;SRMR = .031,RMSEA = .10). Tests of measurement invariance indicated the respondent’s role in the clinical setting (i.e., clinician vs. non-clinician) and years in current role (&lt; 10 years vs. ≥10 years) were invariant. However, significant variance was found between respondents from three different Research Centers within the IMPACT consortium. The second-order mIRT model demonstrated acceptable fit based on most indices (M2(56) = 148.69, p &lt; .001; RMSEA = 0.059, 90% CI[0.048, 0.071];SRMSR = 0.057; CFI = 0.917), though the TLI (0.845) was below the recommended threshold. Item-level fit varied, with RMSEA S-X 2 values indicating six items had acceptable fit, nine items had marginal fit, and five items had poor fit. Conclusions The CSAT Short is recommended to assess sustainability in oncology settings, though users should be cautious when comparing scores across different healthcare systems. Tests of invariance were nonsignificant except for variance by Research Center. Despite some items exhibiting suboptimal fit in mIRT, the overall model fit and reliability were strong. This study advances our understanding of sustainability measurement and the applicability of the CSAT Short across implementation settings and respondents.

  PublisherDOI

• Disparities in the Treatment Engagement Cascade of Collaborative Care for Depression in a Pragmatic Implementation Study

  Psychiatric Services · 2026-01-15 · 2 citations

  articleOpen accessSenior author

  OBJECTIVE: The aim of this study was to examine disparities in treatment engagement in a pragmatic implementation trial of the collaborative care model (CoCM) for depression and anxiety. METHODS: This was a pragmatic, type 2 effectiveness-implementation, randomized rollout study of CoCM. Eleven primary care clinics were randomly assigned an intervention start date and engaged in a 1-year implementation and 1-year sustainment period. Data were extracted from electronic health records of primary care patients attending an associated clinic during the study period (October 1, 2018-January 31, 2023). Treatment engagement cascade steps were screened, referred, assessed, engaged, and completed. Logistic regression models identified demographic predictors (gender, race-ethnicity, age, and insurance status) at each step. RESULTS: A total of 117,949 primary care patients were included (59.3% were female, 78.9% were age <65, and 65.5% were White), and 59,000 patients (50.0%) were screened for CoCM. Screened patients were more likely to be Asian than White (adjusted odds ratio [AOR]=1.11) and less likely to be male (AOR=0.97), Black/African American than White (AOR=0.84), and Medicaid insured (AOR=0.80). Of 1,999 patients referred to CoCM, 469 (20% of 2,329 patients eligible for referral) were CoCM eligible; referred patients were more likely to be Black/African American than White (AOR=1.60) and less likely to be male (AOR=0.72). A total of 986 patients (49% of referred) were assessed, 882 (90% of assessed) were engaged, and 307 (35% of engaged) completed treatment; no demographic differences were observed. CONCLUSIONS: Implementation strategies are needed to increase overall and equitable reach in CoCM treatment engagement for the most vulnerable patients.

  PublisherOA PDFDOI

• The association of urinary sodium with incident apparent treatment resistant hypertension among African Americans: findings from the Jackson Heart Study

  Journal of Human Hypertension · 2026-04-08

  articleOpen access

  Hypertension is a leading cause of cardiovascular disease and disproportionately affects African American (AA) adults. Apparent treatment-resistant hypertension (aTRH) is highly prevalent in this population. Sodium intake is associated with blood pressure (BP) levels, yet the relationship between sodium and the risk of developing aTRH in AA adults remains unclear. This study examined the association between 24-hour urinary sodium excretion and incident aTRH among AA adults with hypertension, using data from the Jackson Heart Study (JHS). The JHS included 5306 self-identified AA adults from Jackson, Mississippi, with data collected from 2000 to 2013. This analysis included 452 participants with baseline hypertension and complete urinary excretion and medication data. Sodium excretion was categorized into quartiles: Q1 (253 to 2530 mg/day), Q2 (2553 to 3657 mg/day), Q3 (3680 to 4692 mg/day), and Q4 (4715 to 9775 mg/day). A semi-parametric proportional hazards model was used to determine the association between sodium excretion and incident aTRH. Participants had a mean age of 63 years, and 27.7% were men. Over a median follow-up of 7.5 years, 123 participants (27.2%) developed aTRH. The incidence of aTRH was 25.7%, 24.8%, 29.2%, and 29.2% in Q1, Q2, Q3, and Q4 of urinary sodium excretion, respectively. In adjusted models, there was no significant association between urinary sodium excretion and incident aTRH [HRs (95% CIs): Q2 = 0.71 (0.34, 1.46), Q3 = 1.02 (0.50, 2.06), Q4 = 0.95 (0.46, 2.00); P = 0.166]. Among AA adults with treated hypertension, sodium intake, as measured by 24-hour urinary sodium excretion, was not significantly associated with incident resistant hypertension.

  PublisherOA PDFDOI

• Effectiveness–implementation hybrid studies to speed the translation of complex health interventions into practice

  2026-01-21 · 1 citations

  book-chapter

  Research to develop and test complex health interventions has traditionally followed a multistage process encompassing (1) efficacy research (i.e. explanatory trials), to confirm the intervention’s effects under tightly controlled conditions; (2) clinical effectiveness research (i.e. effectiveness or pragmatic trials), to confirm the intervention’s effectiveness within routine practice settings and populations; and finally, (3) implementation research, to assess barriers and facilitators to use of the intervention in routine practice and to test strategies that support the intervention’s uptake and integration into care. This chapter describes an alternative research paradigm, called the hybrid effectiveness–implementation approach, which blends characteristics of effectiveness research and implementation research within a set of hybrid effectiveness–implementation studies – referred to as hybrid studies. The goal of this approach is to speed the translation of scientific discoveries into practice and optimise the use of scientific resources.

  PublisherDOI

• Virtual Practice Facilitation and Implementation of Cardiovascular Quality Improvement Strategies in Primary Care Clinics: A Descriptive Study

  The Joint Commission Journal on Quality and Patient Safety · 2026-04-01

  article
  PublisherDOI

• Additional file 1 of Implementation outcomes of a symptom management intervention in ambulatory oncology practices evaluated using a cluster randomized stepped-wedge trial design

  Figshare · 2026-01-01

  articleOpen access1st authorCorresponding

  Additional file 1.

  PublisherDOI

• Additional file 1 of Psychometric properties of the Clinical Sustainability Assessment Tool (CSAT) short form across three research centers evaluating effectiveness and implementation of a cancer symptom surveillance and management intervention

  Figshare · 2026-01-01

  articleOpen accessSenior author

  Additional file 1.

  PublisherDOI

• Additional file 1 of Implementation outcomes of a symptom management intervention in ambulatory oncology practices evaluated using a cluster randomized stepped-wedge trial design

  Open MIND · 2026-01-01

  article1st authorCorresponding

  Additional file 1.

  DOI

• A stakeholder engagement method to inform adaptation of a multicomponent hypertension control program in Ghana: A mixed methods study

  Implementation Science Communications · 2026-04-01

  articleOpen accessSenior author

  BACKGROUND: Hypertension prevalence in Ghana is high, yet diagnosis, treatment, and control rates remain low. The Kaiser Permanente hypertension control program ("Kaiser bundle") has demonstrated success in high-income settings and has been implemented in some low-resource contexts but not in Ghana. This study describes a community-engaged, mixed-methods process to plan the equitable implementation of the Kaiser bundle for hypertension control in Ghanaian primary healthcare centers (PHCs). METHODS: We conducted five iterative workgroup meetings over 9 months with 46 participants, including 15 adults with hypertension, 16 healthcare providers, 6 policymakers, and 9 community leaders and Civil Society Organization representatives. Using semi-structured discussions, human-centered design activities, and surveys. Workgroup transcripts were analyzed using framework-guided rapid turnaround qualitative analysis, applying the Consolidated Framework for Implementation Research and the Expert Recommendations for Implementing Change compilation, and the to identify determinants and generate and specify strategies. Survey ratings informed prioritization of strategies. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was applied to define and organize implementation outcomes, while the Implementation Research Logic Model (IRLM) was used to organize the determinants/strategies and link them to hypothesized mechanisms and outcomes. RESULTS: The Stakeholder groups identified 45 implementation determinants across individual, organizational, and community levels, with barriers such as limited access to care, provider shortages, fragmented health systems, and financial constraints, while facilitators included community partnerships and existing BP screening initiatives. Based on these determinants, the stakeholder groups co-developed 29 discrete implementation strategies targeting the Kaiser bundle components. Strategies emphasized infrastructure strengthening, provider training, community engagement, telemedicine integration, and culturally responsive approaches. The finalized IRLM mapped and linked determinants, strategies, mechanisms, and anticipated outcomes, providing a transparent and equity-focused implementation plan. CONCLUSIONS: Combining community engagement with established implementation science frameworks enabled the development of an implementation plan for adapting the Kaiser bundle in Ghana. This approach offers a replicable model for planning and reporting implementation efforts in low-resource settings and highlights the importance of equity-focused strategies for improving hypertension outcomes.

  PublisherDOI

Recent grants

• NIH Grant U18DP006255

  NIH · $3.8M · 2018

• Optimizing the Implementation of a Population Panel Management Intervention in Safety-Net Clinics for Childhood Hypertension

  NIH · $738k · 2019–2022

Frequent coauthors

• Neil Jordan

  Institute of Public Health Zadar

  82 shared

• C. Hendricks Brown

  Midwestern University

  59 shared

• Matthew J. Smith

  University of Michigan–Ann Arbor

  51 shared

• Cady Berkel

  Arizona State University

  40 shared

• Morris D. Bell

  VA Connecticut Healthcare System

  39 shared

• Thomas J. Dishion

  37 shared

• Allison J. Carroll

  37 shared

• Brittany Ross

  University of Michigan–Ann Arbor

  36 shared

Education

• B.S., Basic Sciences

  Utah Valley University

• M.D.

  Texas College of Osteopathic Medicine

• Other, Family Practice Residency

  Long Island Community Medical Center

• Other, Genitourinary Medicine Fellowship

  Smith Institute for Urology